NOTE: You will need your Bank Account Number, Transit Number, and Institution Number to Invest.

This investment is only open to Accredited Investors, and immediate Friends, Family, and Close Business Associates of the issuer.  

To invest in LyfeMD, you will be investing via a Special Purpose Vehicle (SPV) and not investing directly.  You will NOT appear on the cap table of the issuer.  

What is a Special Purpose Vehicle (SPV)?

A Special Purpose Vehicle is a corporation or limited partnership formed for a specific purpose.  In investing, a special purpose vehicle is typically used to allow smaller investors to pool their funds together in one company before then having that company invest in an underlying business.  The purpose of the SPV is to allow the underlying business to have few investors on its cap table and to consolidate the management of multiple smaller investors outside the main company.  

SPV Name: Firehood LyfeMD SPV Limited Partnership

General Partner: 1001007248 Ontario Inc.

Managed by: Equivesto & Danielle Graham (Firehood)

Additional fees for SPV: None

SPV will invest all funds received directly into LyfeMD Inc.

Minimum Raise: N/A - There is no minimum raise requirement

Target Raise: $1,000,000 for 1,000,000 Class B Units at $1.00 per Class B Unit.

Round Final Close: November 30, 2024 (the issuer may chose to close funds earlier than this date, and may have multiple closings).

Minimum investment amount: $10,000.00

Securities offered: Class B Units

Please see Limited Partnership Agreement for full details of the structure of the SPV and the rights of the units.  You must create an account on Equivesto to view attached documents.  Data Room available upon request.

NOTE: You will need your Bank Account Number, Transit Number, and Institution Number to Invest.

This investment is only open to Accredited Investors, and immediate Friends, Family, and Close Business Associates of the issuer.  

This investment is via a SAFE (Simple Agreement for Future Equity). 

What is a SAFE?

A SAFE allows investors to invest funds at no fixed valuation, and instead have their investment convert into shares at a future investment date, where there will be a fixed valuation.  The SAFE agreement includes a Valuation Cap, so that no matter the valuation of the future round, the number of shares they are given will be based on the pre-set fixed valuation cap.  To reward investors for investing earlier, investors will have a discount rate applied to their investment at the future valuation date, which further discounts the potential future valuation and rewards SAFE investors with more shares.  If there is no future investment round, SAFE investors have priority over other investors and shareholders if the company is closed or sold.  

Post-money valuation Cap (After investment received): CAD $5,000,000

Discount Rate: 80% (meaning your investment will convert at 80% of the value of the future valuation at the time of conversion)

Minimum Raise: N/A - There is no minimum raise requirement

Max Raise: $1,000,000 for 1,000,000 SAFE Units (convertible into Preferred Shares) at $1.00 per SAFE Unit.

Round Final Close: November 30, 2024 (the issuer may chose to close funds earlier than this date, and may have multiple closings).

Minimum investment amount: $10,000.00

Securities offered: SAFE Units that convert into Preferred Shares

Please see SAFE Agreement and Articles of Incorporation for full details of rights associated with the SAFE Units & Preferred Shares.  You must create an account on Equivesto to view attached documents.  Data Room available upon request.

The information contained within this offering page and related presentations constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) sources, availability, and the use of proceeds from third-party financing for the Company’s projects; (iii) the expected development of the Company’s business, projects, and partnerships; (iv) execution of the Company’s vision and growth strategy; and (v) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. 

These statements should not be taken as guarantees of future performance, and undue reliance should not be placed upon them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. 

Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. 

Please review the Issuer’s Business and Risks sections of the Offering Document or Offering Memorandum if available for full explanations of the material factors, assumptions used and risks. 

The forward-looking statements have been approved by management as of the launch date of this offering.